Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Olema Oncology Announces Clinical Trial Agreement to Evaluate OP-1250 in Combination with Palbociclib (IBRANCE®) in Advanced Metastatic Breast Cancer
Monday, November 16, 2020Olema Oncology a clinicalstage biopharmaceutical company focused on the discovery development and commercialization of targeted therapies for womens cancers announced a clinical trial agreement to evaluate OP a complete estrogen receptor ER antagonis...
Jubilant Therapeutics and OneThree Biotech Collaborate to Advance Precision Oncology
Friday, November 13, 2020Jubilant Therapeutics Inc Jubilant a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases and OneThree Biotech a company redesigning drug discovery with biologydriven artific...
Taiho and Lung Therapeutics Enter Into an Exclusive License Agreement in Japan for LTI-01, Treatment for Loculated Pleural Effusions
Friday, November 13, 2020Taiho Pharmaceutical Co Ltd and Lung Therapeutics Inc Lung Tx announced an exclusive license agreement of LTI a recombinant human singlechain urokinase plasminogen activator currently under development by Lung Tx for loculated pleural effusions for t...
Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2
Thursday, November 12, 2020Pfizer and BioNTech SE announced that they have reached an agreement with the European Commission to supply million doses of their investigational BNTb mRNAbased vaccine candidate against SARSCoV to European Union EU Member States with an option for...
Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab
Thursday, November 12, 2020Xencor MorphoSys AG and Incyte announced a clinical collaboration to investigate the combination of tafasitamab plamotamab and lenalidomide in patients with relapsed or refractory diffuse large Bcell lymphoma DLBCL firstline DLBCL and relapsed or ref...
Prestige Biopharma and Teva Israel Announce License and Supply Agreement to Commercialize Prestige's Trastuzumab Biosimilar (Tuznue™) in Israel
Wednesday, November 11, 2020Prestige BioPharma Ltd and Abic Marketing Ltd a subsidiary of Teva Pharmaceutical Industries Ltd announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Prestige Bio...
Medigen and BlueWillow Biologics Partner to Develop Intranasal Vaccine for SARS-CoV-2
Wednesday, November 11, 2020Medigen Vaccine Biologics Corporation a biopharmaceutical company focusing on the development and production of vaccines and biologics and BlueWillow Biologics Inc a privately held clinicalstage biopharmaceutical company developing intranasal vaccine...
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
Tuesday, November 10, 2020Insilico Medicine a leader in deep generative reinforcement learning for target discovery small molecule generation and prediction of clinical trial outcomes announced that it entered into a multitarget drug discovery agreement with Janssen Pharmaceu...
Ultragenyx Announces Plans to Build Large-scale Gene Therapy Manufacturing Facility to Support Pipeline of Therapies for Rare Diseases
Tuesday, November 10, 2020Ultragenyx Pharmaceutical Inc a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultrarare genetic diseases today announced that it plans to build a new largescale gene therapy manufacturing fa...
Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
Monday, November 09, 2020Vifor Pharma and Angion Biomedica Corp Angion announced the signing of a licensing agreement for the commercialization of ANG currently developed for treatment of delayed graft function DGF and cardiac surgeryassociated acute kidney injury CSAAKI ANG...
